Management of polymyalgia rheumaticaBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c620 (Published 04 February 2010) Cite this as: BMJ 2010;340:c620
- Eleana Ntatsaki, specialist registrar in rheumatology1,
- Richard A Watts, consultant rheumatologist1
- 1Rheumatology Department, Ipswich Hospital NHS Trust, Ipswich IP4 5PD
Evidence is lacking on the management of polymyalgia rheumatica.1 The recent guidelines published by the British Society for Rheumatology (BSR) and the British Health Professionals in Rheumatology (BHPR) are a brave attempt to give some structure to the diagnosis and treatment of this condition.2
Polymyalgia rheumatica is one of the most common inflammatory rheumatic diseases in elderly people. It is characterised by pain and stiffness, usually of sudden onset, affecting the limb girdle areas (shoulder and hip), neck, and torso.3 Its prevalence in people aged over 50 is about 700 per 100 000.4 It has many non-specific features and a wide differential diagnosis. No “gold standard” diagnostic test is available, so the diagnosis is often made on clinical grounds. This can lead to diagnostic error.
Polymyalgia rheumatica is managed mainly in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial